- Home
- FWONA vs HOLX Comparison
FWONA vs HOLX Comparison
Compare FWONA & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWONA | HOLX |
|---|---|---|
| Founded | 1950 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 16.6B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | FWONA | HOLX |
|---|---|---|
| Price | $77.40 | $75.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 13 |
| Target Price | ★ $106.00 | $77.89 |
| AVG Volume (30 Days) | 149.4K | ★ 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $24.56 | $4.74 |
| Revenue Next Year | $9.89 | $5.03 |
| P/E Ratio | $97.75 | ★ $95.46 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $68.00 | $51.90 |
| 52 Week High | $99.49 | $75.75 |
Technical Indicators
Market Signals| Indicator | FWONA | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 42.88 | 50.04 |
| Support Level | $76.09 | $75.20 |
| Resistance Level | $91.32 | $75.35 |
| Average True Range (ATR) | 2.98 | 0.19 |
| MACD | -0.32 | -0.02 |
| Stochastic Oscillator | 20.62 | 19.38 |
Price Performance
Historical ComparisonAbout FWONA Liberty Media Corporation Series A Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.